Coronary vasospasm should be considered as a mimic of obstructive coronary disease in patients with immune checkpoint inhibitor myocarditis presenting as STEMI.
Coronary vasospasm can mimic obstructive coronary disease and should be considered in immune checkpoint inhibitor myocarditis. Multisystem immune-related adverse events, including myocarditis, pericarditis, and hypophysitis, may present simultaneously and require prompt multidisciplinary care.
Ali et al. (Wed,) studied this question.